Jay Graham, MD
Surgery · Newark, NJNPI 1932116530
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Veloxis Pharmaceuticals, Inc. accounts for 80.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $22,388 and has fallen 98.6% since, to $309 in 2025. Among surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $590.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veloxis Pharmaceuticals, Inc.$63K
- Sanofi-aventis U.S. LLC$13K
- AbbVie$622
- Dilon Technologies, Inc.$310
- Paragonix Technologies, Inc.$259
- Johnson & Johnson$202
- plus $537 from 9 others
Across 2 payments — averaging $303.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Transmedics, Inc.$606
What the payments were for
- Consulting fees$38,90450%
- Speaking & faculty fees$21,93828%
- Travel & lodging$11,94315%
- Food & beverage$4,5696%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 75 | $62,586 |
| Sanofi-aventis U.S. LLC | 13 | $12,851 |
| AbbVie | 18 | $622 |
| Dilon Technologies, Inc. | 2 | $310 |
| Paragonix Technologies, Inc. | 3 | $259 |
| Johnson & Johnson | 5 | $202 |
| Medtronic | 3 | $123 |
| E.r. Squibb & Sons, L.L.C. | 2 | $109 |
| Covidien LP | 3 | $88 |
| Calliditas Therapeutics US Inc. | 2 | $73 |
| Potrero Medical, Inc. | 1 | $44 |
| Coloplast | 1 | $36 |
| W. L. Gore & Associates, Inc. | 1 | $22 |
| Convatec Inc. | 1 | $22 |
| Sanofi | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Envarsus$61,890
- THYMOGLOBULIN$12,421
- HemoBlast Bellows$310
- Mavyret$226
- ECHELON FLEX Stapler$115
- ECHELON ENDOPATH Stapler$115
How this compares
$77,368 in reported general payments places this provider in the 95th percentile of 593 surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 15 | $863 |
| Prednisone | 13 | $123 |
Paid to pharmacies, not to this prescriber.
Other surgery in Newark
- Sharique NazirNewark$54K
- Eduardo Espinoza OlorteguiNewark$27K
- Robert PerezHainesport$2M
- Eric WhitmanMorristown$848K
- Jarrod KaufmanBrick$474K
- Amit TrivediParamus$242K
- Young HongCamden$203K
- Harvey RainvilleGlen Ridge$159K
- Harrison CotlerOakhurst$149K
- Francis PrevitiNorth Field$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.